… In the EGFR mutation status subgroup, we also … efficacy of gefitinib and erlotinib. However,
our results indirectly prove that both gefitinib and erlotinib are more suitable for treating EGFR …

… Variables including age, gender, smoking status, performance status (PS), type of EGFR
mutation, clinical stage at the start of gefitinib therapy, presence/absence of brain metastasis, …

… In the subgroup of 437 patients analyzed for the presence of EGFR mutation, there was a
significant interaction between treatment efficacy and EGFR mutation status. Namely, …

… Treatment arms with gefitinib 250mg/day and platinum-based doublets chemotherapy …
estimates for efficacy and safety outcomes of interest. RESULTS: We identified 7 gefitinib and 41 …

… the efficacy of gefitinib and the epidermal growth factor receptor (EGFR) mutation to gefitinib
… had failed at least one platinum-based regimen received gefitinib 250 mg once daily. The …

… gefitinib (GEF). The goal of this study was to assess EGFR mutations, as well as expression
of EGFR and related molecules by immunohistochemistry (IHC) as predictors of GEF efficacy…

… efficacy could still be maintained. Clinical data on efficacy of reduced dose gefitinib treatment
… NSCLC patients with sensitizing EGFR mutations, trough concentration of gefitinib was not …

… Our study examined the efficacy and safety of gefitinib combined with carboplatin and
pemetrexed for first-line treatment of advanced NSCLC with sensitive EGFR mutations. The study …

… EGFR mutation, we also found no difference between the 2 EGFR TKIs in the comparison of
antitumor effectiveness… that both gefitinib and erlotinib are more suitable for EGFR mutation–…

… , gefitinib, afatinib and icotinib shared equivalent efficacy but presented different efficacy-toxicity
pattern for EGFR-mutated … Erlotinib and afatinib revealed potentially better efficacy but …